Summary
Human gene transfer with gammaretroviral, murine leukemia virus (MLV) based vectors has been shown to effectively insert and express transgene sequences at a level of therapeutic benefit. However, there are numerous reports of disruption of the normal cellular processes caused by the viral insertion, even of replication deficient gammaretroviral vectors. Current gammaretroviral and lentiviral vectors do not control the site of insertion into the genome, hence, the possibility of disruption of the target cell genome. Risk related to viral insertions is linked to the number of insertions of the transgene into the cellular DNA, as has been demonstrated for replication competent and replication deficient retroviruses in experiments. At high number of insertions per cell, cell transformation due to vector induced activation of proto-oncogenes is more likely to occur, in particular since more than one transforming event is needed for oncogenesis. Thus, determination of the vector copy number in bulk transduced populations, individual colony forming units, and tissue from the recipient of the transduced cells is an increasingly important safety assay and has become a standard, though not straightforward assay, since the inception of quantitative PCR.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Baum, C., Dullmann, J., Li, Z., Fehse, B., Meyer, J., Williams, D.A. and von Kalle, C. (2003) Side effects of retroviral gene transfer into hematopoietic stem cells. Blood, 101, 2099–2114.
Hacein-Bey-Abina, S., Von Kalle, C., Schmidt, M., McCormack, M.P., Wulffraat, N., Leboulch, P., Lim, A., Osborne, C.S., Pawliuk, R., Morillon, E. et-al. (2003) LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science, 302, 415–419.
Li, Z., Dullmann, J., Schiedlmeier, B., Schmidt, M., von Kalle, C., Meyer, J., Forster, M., Stocking, C., Wahlers, A., Frank, O. et-al. (2002) Murine leukemia induced by retroviral gene marking. Science, 296, 497.
Du, Y., Spence, S.E., Jenkins, N.A. and Cope- and, N.G. (2005) Cooperating cancer-gene identification through oncogenic-retrovirus-induced insertional mutagenesis. Blood, 106, 2498–2505.
Du, Y., Jenkins, N.A. and Copeland, N.G.(2005) Insertional mutagenesis identifies genes that promote the immortalization of primary bone marrow progenitor cells. Blood, 106, 3932–3939.
Modlich, U., Kustikova, O.S., Schmidt, M., Rudolph, C., Meyer, J., Li, Z., Kamino, K., von Neuhoff, N., Schlegelberger, B., Kuehl-cke, K. et-al. (2005) Leukemias following retroviral transfer of multidrug resistance 1(MDR1) are driven by combinatorial inser-tional mutagenesis. Blood, 105, 4235–4246.
Holland, P.M., Abramson, R.D., Watson, R.and Gelfand, D.H. (1991) Detection of specific polymerase chain reaction product by utilizing the 5 --3 exonuclease activity of Thermus aquaticus DNA polymerase. Proc Natl Acad Sci USA, 88, 7276–7280.
Chen, J., Reeves, L., Sanburn, N., Croop, J.,Williams, D.A. and Cornetta, K. (2001) Packaging cell line DNA contamination of vector supernatants: implication for laboratory and clinical research. Virology, 282, 186–197.
Sastry, L., Xu, Y., Cooper, R., Pollok, K. and Cornetta, K. (2004) Evaluation of plasmid DNA removal from lentiviral vectors by benzo-nase treatment. Hum Gene Ther, 15, 221–226.
Will, E., Bailey, J., Schuesler, T., Modlich, U., Balcik, B., Burzynski, B., Witte, D., Layh-Schmitt, G., Rudolph, C., Schlegelberger, B. et-al.. (2007) Importance of murine study design for testing toxicity of retroviral vectors in support of phase I trials. Mol Ther, 15, 782–791.
Villella, A.D., Yao, J., Getty, R.R., Juliar, B.E., Yiannoutsos, C., Hartwell, J.R., Cai, S., Sadat, M.A., Cornetta, K., Williams, D.A. et-al. (2005) Real-Time PCR: An Effective Tool for Measuring Transduction Efficiency in Human Hematopoietic Progenitor Cells. Mol Ther, 11, 483–491.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Schuesler, T., Reeves, L., Kalle, C.v., Grassman, E. (2009). Copy Number Determination of Genetically-Modified Hematopoietic Stem Cells. In: Baum, C. (eds) Genetic Modification of Hematopoietic Stem Cells. Methods In Molecular Biology™, vol 506. Humana Press. https://doi.org/10.1007/978-1-59745-409-4_19
Download citation
DOI: https://doi.org/10.1007/978-1-59745-409-4_19
Publisher Name: Humana Press
Print ISBN: 978-1-58829-980-2
Online ISBN: 978-1-59745-409-4
eBook Packages: Springer Protocols